Recent Advances in Lab-on-a-Chip and Tissue Repair Technologies

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across lab-on-chip technology and tissue repair engineering. Particular focus is on advanced microfluidics and wound healing. The corresponding clinical trials scenario is depicted, along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cel

Table of Contents

Recent Advances in Lab-on-a-Chip and Tissue Repair TechnologiesInnovations in Microfluidic and Wound Healing PlatformsAffordable Lab-on-a-Chip Platform3D Printed Microfluidic DeviceTissue Nanotransfection Platform for Facilitating Cell RepairNovel Skin-Regeneration PlatformClinical Trial Analysis and Industry InteractionsAnalysis of Clinical Studies Leveraging Microfluidic Platforms Across Infertility and Preterm Birth IndicationsSummary of Key Contacts

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.